Abstract

Tinnitus is not a disease, but rather a symptom or condition characterized by a conscious perception of an unreal sound in the absence of external auditory stimulus. This ontological condition can modify everyday life in different ways: causing distress and annoyance, sleep disruption, anxiety and depression. The World Health Organization (WHO) describes tinnitus as a symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, grinding, hissing, roaring or other noises in the ear. Even if different treatments exist for “tinnitus-related abnormalities” such as cognitive behavioural therapy and/or sound therapy, no effective pharmacological approach is available, although much research is underway into the mechanism and possible treatments. Furthermore, no drugs are currently approved by the FDA for treatment of spontaneous idiopathic tinnitus, and few drugs reliably suppress or eliminated chronic tinnitus in the majority of patients. A large number of researches have been conducted to evaluate the efficacy of different classes of drugs in alleviating the symptoms of tinnitus. Tricyclic antidepressant, selective-serotonin-reuptake inhibitors, benzodiazepine, anticonvulsant agents, local anesthetics, diuretics, anticoagulants and vasodilators are just some of the drugs that have been taken into account to improve the quality of life and reduce awareness of-and reaction to-tinnitus. In this chapter, current evidence on emerging pharmacological approaches to tinnitus will be described and examined in terms of mechanism of action and effectiveness.
Lingua originaleEnglish
Titolo della pubblicazione ospiteTinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments
Pagine43-64
Numero di pagine22
Stato di pubblicazionePublished - 2016

Fingerprint

Tinnitus
Pharmacology
Therapeutics
Pharmaceutical Preparations
Hearing Disorders
Tricyclic Antidepressive Agents
Serotonin Uptake Inhibitors
Cognitive Therapy
Local Anesthetics
Benzodiazepines
Vasodilator Agents
Research
Diuretics
Anticonvulsants
Anticoagulants
Ear
Noise
Sleep
Anxiety
Quality of Life

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cita questo

Brancato, A. (2016). Emerging pharmacological treatments of tinnitus. In Tinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments (pagg. 43-64)

Emerging pharmacological treatments of tinnitus. / Brancato, A.

Tinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments. 2016. pag. 43-64.

Risultato della ricerca: Chapter

Brancato, A. 2016, Emerging pharmacological treatments of tinnitus. in Tinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments. pagg. 43-64.
Brancato, A. Emerging pharmacological treatments of tinnitus. In Tinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments. 2016. pag. 43-64
Brancato, A. / Emerging pharmacological treatments of tinnitus. Tinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments. 2016. pagg. 43-64
@inbook{6a1e7a6ff6914c3cb99efe3a8f4dc5c1,
title = "Emerging pharmacological treatments of tinnitus",
abstract = "Tinnitus is not a disease, but rather a symptom or condition characterized by a conscious perception of an unreal sound in the absence of external auditory stimulus. This ontological condition can modify everyday life in different ways: causing distress and annoyance, sleep disruption, anxiety and depression. The World Health Organization (WHO) describes tinnitus as a symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, grinding, hissing, roaring or other noises in the ear. Even if different treatments exist for {\^a}€œtinnitus-related abnormalities{\^a}€ such as cognitive behavioural therapy and/or sound therapy, no effective pharmacological approach is available, although much research is underway into the mechanism and possible treatments. Furthermore, no drugs are currently approved by the FDA for treatment of spontaneous idiopathic tinnitus, and few drugs reliably suppress or eliminated chronic tinnitus in the majority of patients. A large number of researches have been conducted to evaluate the efficacy of different classes of drugs in alleviating the symptoms of tinnitus. Tricyclic antidepressant, selective-serotonin-reuptake inhibitors, benzodiazepine, anticonvulsant agents, local anesthetics, diuretics, anticoagulants and vasodilators are just some of the drugs that have been taken into account to improve the quality of life and reduce awareness of-and reaction to-tinnitus. In this chapter, current evidence on emerging pharmacological approaches to tinnitus will be described and examined in terms of mechanism of action and effectiveness.",
keywords = "Medicine (all)",
author = "{Brancato, A.} and Carla Cannizzaro and Francesco Martines and Fulvio Plescia and Pietro Salvago and Federico Sireci",
year = "2016",
language = "English",
isbn = "9781634841559",
pages = "43--64",
booktitle = "Tinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments",

}

TY - CHAP

T1 - Emerging pharmacological treatments of tinnitus

AU - Brancato, A.

AU - Cannizzaro, Carla

AU - Martines, Francesco

AU - Plescia, Fulvio

AU - Salvago, Pietro

AU - Sireci, Federico

PY - 2016

Y1 - 2016

N2 - Tinnitus is not a disease, but rather a symptom or condition characterized by a conscious perception of an unreal sound in the absence of external auditory stimulus. This ontological condition can modify everyday life in different ways: causing distress and annoyance, sleep disruption, anxiety and depression. The World Health Organization (WHO) describes tinnitus as a symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, grinding, hissing, roaring or other noises in the ear. Even if different treatments exist for “tinnitus-related abnormalities” such as cognitive behavioural therapy and/or sound therapy, no effective pharmacological approach is available, although much research is underway into the mechanism and possible treatments. Furthermore, no drugs are currently approved by the FDA for treatment of spontaneous idiopathic tinnitus, and few drugs reliably suppress or eliminated chronic tinnitus in the majority of patients. A large number of researches have been conducted to evaluate the efficacy of different classes of drugs in alleviating the symptoms of tinnitus. Tricyclic antidepressant, selective-serotonin-reuptake inhibitors, benzodiazepine, anticonvulsant agents, local anesthetics, diuretics, anticoagulants and vasodilators are just some of the drugs that have been taken into account to improve the quality of life and reduce awareness of-and reaction to-tinnitus. In this chapter, current evidence on emerging pharmacological approaches to tinnitus will be described and examined in terms of mechanism of action and effectiveness.

AB - Tinnitus is not a disease, but rather a symptom or condition characterized by a conscious perception of an unreal sound in the absence of external auditory stimulus. This ontological condition can modify everyday life in different ways: causing distress and annoyance, sleep disruption, anxiety and depression. The World Health Organization (WHO) describes tinnitus as a symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, grinding, hissing, roaring or other noises in the ear. Even if different treatments exist for “tinnitus-related abnormalities” such as cognitive behavioural therapy and/or sound therapy, no effective pharmacological approach is available, although much research is underway into the mechanism and possible treatments. Furthermore, no drugs are currently approved by the FDA for treatment of spontaneous idiopathic tinnitus, and few drugs reliably suppress or eliminated chronic tinnitus in the majority of patients. A large number of researches have been conducted to evaluate the efficacy of different classes of drugs in alleviating the symptoms of tinnitus. Tricyclic antidepressant, selective-serotonin-reuptake inhibitors, benzodiazepine, anticonvulsant agents, local anesthetics, diuretics, anticoagulants and vasodilators are just some of the drugs that have been taken into account to improve the quality of life and reduce awareness of-and reaction to-tinnitus. In this chapter, current evidence on emerging pharmacological approaches to tinnitus will be described and examined in terms of mechanism of action and effectiveness.

KW - Medicine (all)

UR - http://hdl.handle.net/10447/247607

UR - https://www.novapublishers.com/catalog/product_info.php?products_id=56554

M3 - Chapter

SN - 9781634841559

SP - 43

EP - 64

BT - Tinnitus: Epidemiology, Causes and Emerging Therapeutic Treatments

ER -